Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Enphase Energy Introduces Power Control Software to Improve Commercial Solar Economics
-
Agereh Secures First Commercial Customer with Multi-Terminal Deployment at Major U.S. Airport
-
Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases
-
Spazious & FirstView Join Visiting Media to Build a Global Platform for Immersive Hospitality Sales
-
BLAQclouds Announces Launch of ApolloNFT.io Marketplace Built on Apollo Mainnet
-
Carpenter Technology Announces CEO Transition Plan: Brian Malloy to Succeed Tony Thene as Chief Executive Officer on July 1, 2026; Tony Thene to Continue as Executive Chairman
-
Holzer & Holzer, LLC Reminds VTGN Investors of the March 16, 2026 Lead Plaintiff Deadline in the Vistagen Therapeutics, Inc. Securities Class Action
-
Kratos Awarded Multi-Million Dollar Ground System Contract by Airbus to Support OmanSat-1
-
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
-
DryRun Security Appoints Andrew Peterson to Board of Directors
-
Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
-
Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
-
New Teleport Research Reveals AI Security Crisis in the Enterprise: Over-Privileged AI Systems Drive 4.5x Higher Incident Rates
-
Lumanity Becomes First Life Sciences Value Demonstration Partner to Achieve ISO 42001 Certification, Setting a New Standard for Responsible AI in Life Sciences
-
Seanergy Maritime Reports Strong Fourth Quarter and Full-Year 2025 Results
-
Spazious & FirstView Join Visiting Media to Build a Global Platform for Immersive Hospitality Sales
-
Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks
-
SEALSQ Announces FY 2025 Key Preliminary / Unaudited Financials Metrics: Reports 66% Year Over Year Revenue Growth to $18 Million
-
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
-
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
-
Mutuum Finance (MUTM) Reports Accelerated Roadmap Execution with V1 Protocol Activated
-
EagleNXT MicaSense™ RedEdge-P Triple Sensor Array Drives Advanced Climate Research
-
LGI Homes, Inc. Reports Fourth Quarter and Full Year 2025 Results and Issues Guidance for 2026
-
Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
NSA Labs Helps Leading Biopharmaceutical Companies Get Study Results Faster on Proscia’s Platform
-
IP Strategy Issues Statement on Aria’s Frontline K-Pop Release with RESCENE, Highlighting AI-Native Music Ownership on Story
-
Westervelt Ecological Services Welcomes Corblu Ecology Group, Strengthening a Shared Commitment to Long-Term Conservation
-
ARKO Corp. and ARKO Petroleum Corp. Announce Closing of ARKO Petroleum Corp.’s Initial Public Offering
-
DIRTT Enters into Support Agreement and Appoints New Director
-
Refinity Validates Breakthrough Waste Conversion Technology, Advancing Toward Commercial Demonstration
-
Kite Realty Group Reports Fourth Quarter and Full Year 2025 Operating Results and Provides 2026 Guidance
-
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25
-
Vongvanith Named Kinetic’s First Chief Customer Officer; Brings Customer Voice to Senior Leadership
-
Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
-
Extendicare Announces February 2026 Dividend of C$0.042 per Share
-
Builders Movement Launches “Turn Out or Roll Over” Campaign to Ensure Texas Primary Election Reflects the Broad Will of Texans
-
Fulcrum Therapeutics to Present 12-Week Data from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
-
Aprea Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026
-
Globavend reports strong 2025 financial results with 42% revenue growth
-
Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Appoints Travis Yakimishyn as Chief Electrical & Power Systems Officer to Accelerate Texatron™ Commercial Deployment
-
Absci to Participate in Upcoming Investor Conferences
-
MediWound to Present at Upcoming Investor Conferences
-
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy
-
CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors
-
Nuclear Waste Disposal Technology Provider Deep Isolation Appoints Joseph Nelson as Chief Financial Officer to Strengthen Commercial Readiness
-
Oxford Lane Capital Corp. Provides January 2026 Net Asset Value Update
-
Vestaron Secures EPA Approval for BASIN™ Bioinsecticide on Outdoor Crops
-
Mark Levin to Launch New Vodcast Series Across YouTube and Rumble
-
TMD Energy Limited Announces Changes to Its Board of Directors
